Loading
Life sciences · Review
Neurology and Therapy · October 30, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Review.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Migraine is a highly prevalent and disabling neurological disorder that imposes a substantial health, social, and economic burden, including significant impacts on workforce participation and productivity. Despite advances in treatment and increased recognition of its burden, migraine remains underdiagnosed, undertreated, and insufficiently prioritized in many health systems. Barriers across the patient journey continue to limit timely diagnosis, effective management, and equitable access to care. This Global Migraine narrative review and expert perspective seek to promote international alignment on the burden of migraine and provide evidence-informed guidance to improve care, workplace support, and policy development worldwide. A two-stage methodology was applied. First, a structured non-systematic literature review synthesized evidence on migraine epidemiology, socioeconomic burden, quality of life, workplace productivity, policies, access to care, and the patient journey. Second, findings were validated and refined through consultations with international experts representing diverse geographies, healthcare systems, and levels of migraine policy development. Two virtual expert panel meetings were held in December 2025 and March 2026, respectively, supported by offline reviews and follow-up consultations. Six key areas of unmet need were identified: diagnosis and disease recognition; knowledge and education; social and psychological impact; access to care; availability and affordability; and treatment quality. Migraine remains largely absent from national health strategies, contributing to fragmented care and inadequate resource allocation. The call-to-action outlines priority recommendations, key stakeholders, and implementation considerations to address these gaps across different health system contexts. Migraine should be recognized as a public health and economic priority. Coordinated strategies are needed to improve diagnosis, care pathways, treatment access, and productivity outcomes, while strengthening global collaboration and policy alignment.